RxDoctor Payments Data

Tamsyn Kellough

Physician Assistant · Kihei, HINPI 1770143026

Payments from drug & device makers

$918in general payments, 2019–2025

Across 16 payments — averaging $57.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$225
  • Medtronic$134
  • Boston Scientific$125
  • Novo Nordisk$105
  • AstraZeneca$104
  • LEO Pharma Inc.$101
  • plus $124 from 3 others

What the payments were for

  • Food & beverage$918100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead2$225
Medtronic2$134
Boston Scientific1$125
Novo Nordisk1$105
AstraZeneca(2 entities)4$104
LEO Pharma Inc.1$101
Nxstage Medical, Inc.2$64
Lilly USA, LLC2$46
Amgen1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$918 in reported general payments places this provider in the 70th percentile of 246 physician assistant providers in Hawaii.

See all physician assistant providers in Hawaii

Medicare billing

Part B allowed, 2024
$39,792
Medicare patients
162
Services billed
451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate12$41,078
JardianceEmpagliflozin12$20,837
EliquisApixaban11$12,844
Atorvastatin Calcium165$2,717
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$2,427
Albuterol Sulfate HfaAlbuterol Sulfate66$1,771
Ezetimibe32$1,762
Losartan Potassium101$1,597
Rosuvastatin Calcium61$1,419
Omeprazole60$1,377
Montelukast Sodium34$995
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide17$761
Amlodipine Besylate115$761
Insulin Lispro Kwikpen U-100Insulin Lispro12$712
Metformin Hcl63$700

Paid to pharmacies, not to this prescriber.

Other physician assistant in Kihei

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →